Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?

Minimal residual disease (MRD) assessment plays a central role in risk stratification and treatment guidance in paediatric patients with acute lymphoblastic leukaemia (ALL). As such, MRD prior to haematopoietic stem cell transplantation (HSCT) is a major factor that is independently correlated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Merli, Pietro, Ifversen, Marianne, Truong, Tony H., Marquart, Hanne V., Buechner, Jochen, Wölfl, Matthias, Bader, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602790/
https://www.ncbi.nlm.nih.gov/pubmed/34805054
http://dx.doi.org/10.3389/fped.2021.777108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602790/
https://www.ncbi.nlm.nih.gov/pubmed/34805054
http://dx.doi.org/10.3389/fped.2021.777108

Ejemplares similares